Clare Thibodeaux, PhD, January 11, 2016


Too many people suffer with a rare disease. The search for treatments is often too slow and prohibitively expensive. But it doesn’t always have to be this way. There is a growing interest in drug repurposing – an approach that can deliver safe and affordable solutions quickly.

Cures Within Reach (, a global nonprofit focused on drug repurposing, has partnered with the Canadian Institutes of Health Research for a new funding initiative. Together they are calling for proposals for research into repurposing drugs specifically for rare diseases indications. This program is designed to encourage collaboration from clinical sites located both in Canada and the United States. A minimum of 10 projects will be selected for funding through this program.

This request for proposals (RFP) entitled “North American Re:Rare” can be viewed on CureAcceleratorTM (, an online platform dedicated to bringing together all those with important contributions to repurposing research. Researchers and clinicians can respond directly to the RFP on CureAccelerator, while patient advocacy groups can join the discussion thread. Simply register for free at For more information, contact Clare Thibodeaux, PhD at

cihr logo-en Mindset Foundation LogoMitacs-logo

Click here to sign up for our eNewsletter today!

Please include your Full Name* and Email Address*


If the link above doesn't work, please contact our Admin support at with your Full Name and Email Address to sign up!


Cures Within Reach

134 N. LaSalle, #1130
Chicago, IL 60602

All funds donated to Cures Within Reach may be tax deductible for federal income tax purposes. 

Partnership for Cures DBA Cures Within Reach is recognized by the IRS as a 501(c)3 tax-exempt not-for-profit organization, tax ID 20-3620169.


Monday the 25th. Copyright 2018 Cures Within Reach.